Cargando…

Simultaneous integrated dose reduction intensity-modulated radiotherapy applied to an elective nodal area of limited-stage small-cell lung cancer

The purpose of this study was to evaluate the clinical efficacy and toxicity of simultaneous integrated dose reduction intensity-modulated radiotherapy (SIR-IMRT) applied to an elective nodal area of patients with limited-stage small-cell lung cancer (LS-SCLC). Between January 2010 and March 2013, 5...

Descripción completa

Detalles Bibliográficos
Autores principales:	LIU, ZHIYAN, LIU, WEISHUAI, JI, KAI, WANG, PING, WANG, XIN, ZHAO, LUJUN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665347/ https://www.ncbi.nlm.nih.gov/pubmed/26668599 http://dx.doi.org/10.3892/etm.2015.2835

Ejemplares similares

Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer
por: Luo, Jing, et al.
Publicado: (2023)

Preliminary Results about Application of Intensity-Modulated Radiotherapy to Reduce Prophylactic Radiation Dose in Limited-Stage Small Cell Lung Cancer
por: Liu, Zhiyan, et al.
Publicado: (2018)

Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?
por: Wang, Peng, et al.
Publicado: (2015)

The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma
por: Zhao, Jingjing, et al.
Publicado: (2020)

Nodal failure patterns and utility of elective nodal irradiation in submandibular gland carcinoma treated with postoperative radiotherapy - a multicenter experience
por: Hsieh, Cheng-En, et al.
Publicado: (2018)

Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy
por: Li, Minglun, et al.
Publicado: (2022)

Reply: Patterns of nodal recurrence after omission of elective nodal irradiation for limited-stage small-cell lung cancer
por: Belderbos, J, et al.
Publicado: (2007)

Involved field radiotherapy (IFRT) versus elective nodal irradiation (ENI) for locally advanced non-small cell lung cancer: a meta-analysis of incidence of elective nodal failure (ENF)
por: Li, Ruijian, et al.
Publicado: (2016)

Evaluation of Exposure Doses of Elective Nodal Irradiation in Chemoradiotherapy for Advanced Esophageal Cancer
por: Tamamura, Hiroyasu, et al.
Publicado: (2023)

Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geometrically driven DVH prediction model
por: Nakamura, Akira, et al.
Publicado: (2019)

Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer
por: Sulman, Erik P, et al.
Publicado: (2009)

Radiotherapy for T3N0 glottic carcinoma without cord fixation: elective nodal irradiation or not?
por: Toya, Ryo, et al.
Publicado: (2017)

Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer
por: Chen, Yang, et al.
Publicado: (2016)

＜Editors’ Choice＞ Elective nodal irradiation versus involved field radiotherapy for limited disease small cell lung cancer: a single-institution experience
por: Suzuki, Gen, et al.
Publicado: (2022)

A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer
por: Li, Chen, et al.
Publicado: (2019)

Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer
por: Chen, Yang, et al.
Publicado: (2018)

Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer
por: Caravatta, Luciana, et al.
Publicado: (2012)

An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer
por: Bisello, Silvia, et al.
Publicado: (2019)

Nodal and osseous oligometastatic prostate cancer: a cohort including the introduction of PSMA-PET/CT-guided stereotactic and hypofractionated radiotherapy with elective nodal therapy
por: Gawish, Ahmed, et al.
Publicado: (2022)

Feasibility of stereotactic radiotherapy for lung lesions and conventional radiotherapy for nodal areas in primary lung malignancies
por: Kim, Yeon Joo, et al.
Publicado: (2018)

Preliminary results on anal cancer by applying intensity modulated radiotherapy and synchronous capecitabine chemotherapy simultaneously
por: Xu, Wei-Dong, et al.
Publicado: (2020)

Failure Patterns of Recurrence in Patients With Localized Esthesioneuroblastoma Following Surgery and Adjuvant Radiotherapy Without Elective Nodal Irradiation
por: Katano, Atsuto, et al.
Publicado: (2023)

Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
por: Bao, Zhirong, et al.
Publicado: (2019)

Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study
por: Lan, Wang, et al.
Publicado: (2022)

Dose Reduction to the Scalp with Hippocampal Sparing Is Achievable with Intensity Modulated Radiotherapy
por: Witek, Matthew, et al.
Publicado: (2014)

Dosimetric evaluation of the feasibility of stereotactic body radiotherapy for primary lung cancer with lobe-specific selective elective nodal irradiation
por: Komatsu, Tetsuya, et al.
Publicado: (2016)

Cardiac dose reduction with deep inspiration breath hold for left-sided breast cancer radiotherapy patients with and without regional nodal irradiation
por: Yeung, Rosanna, et al.
Publicado: (2015)

Patterns of Failure After Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose Coverage
por: Kamal, Mona, et al.
Publicado: (2020)

The role of involved field irradiation versus elective nodal irradiation in definitive radiotherapy or chemoradiotherapy for esophageal cancer- a systematic review and meta-analysis
por: Wang, Hesong, et al.
Publicado: (2022)

Radiotherapy in nodal oligorecurrent prostate cancer
por: Pinkawa, Michael, et al.
Publicado: (2021)

Three-dimensional conformal radiation for esophageal squamous cell carcinoma with involved-field irradiation may deliver considerable doses of incidental nodal irradiation
por: Ji, Kai, et al.
Publicado: (2012)

Low radiotherapy dose is suitable for brain metastases in SCLC compared with high dose
por: Xu, Liming, et al.
Publicado: (2023)

Elective Nodal Irradiation for Oligorecurrent Nodal Prostate Cancer: Interobserver Variability in the PEACE V-STORM Randomized Phase 2 Trial
por: Lorton, Orane, et al.
Publicado: (2023)

Elective nodal dose of 60 Gy or 50 Gy in head and neck cancers: A matched pair analysis of outcomes and toxicity
por: Murthy, Vedang, et al.
Publicado: (2017)

Outcome of dose-escalated intensity-modulated radiotherapy for limited disease small cell lung cancer
por: Yang, Eunyeong, et al.
Publicado: (2023)

Nodal recurrence patterns on PET/CT after RTOG-based nodal radiotherapy for prostate cancer
por: Liskamp, C.P., et al.
Publicado: (2020)

Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
por: Feng, Yanru, et al.
Publicado: (2019)

Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis
por: Cheng, Yun-jie, et al.
Publicado: (2018)

An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: A long-term follow-up result
por: Hung, Tsung-Min, et al.
Publicado: (2017)

Involved-Field Radiotherapy versus Elective Nodal Irradiation in Combination with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Prospective Randomized Study
por: Chen, Ming, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5kv6h8utahjmv6lsbnnmf7g9vf